DCF — ST ELIZABETH HEALTHCARE
Enterprise Value: $-2.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-2.2B
Enterprise Value
$-681.3M
PV of Cash Flows
$-1.5B
PV of Terminal Value
$-2.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-140.6M | -13.0% | $-187.4M | $-170.4M |
| Year 2 | $1.1B | $-133.5M | -12.0% | $-181.7M | $-150.1M |
| Year 3 | $1.2B | $-125.7M | -11.0% | $-175.4M | $-131.8M |
| Year 4 | $1.2B | $-123.5M | -10.0% | $-174.6M | $-119.3M |
| Year 5 | $1.2B | $-124.0M | -10.0% | $-176.7M | $-109.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-2.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13215983906974946
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5